Melanoma, the deadliest form of skin cancer, is diagnosed in more than 130,000 people globally every year. Now, work is being done on a tool to help in its early detection: a simple, compact laser probe that can distinguish between harmless moles and cancerous ones – in a matter of seconds.
“With skin cancer, there’s a saying that if you can spot it you can stop it – and that’s exactly what this probe is designed to do,” said researcher Daniel Louie, a PhD student who constructed the device as part of his studies in biomedical engineering at the University of British Columbia. “We set out to develop this technology using inexpensive materials, so the final device would be easy to manufacture and widely used as a preliminary screening tool for skin cancer.”
The probe works on the principle that light waves change as they pass through objects. The researchers aimed a laser into skin tissue from volunteer patients and studied the changes that occurred to this light beam.
“Because cancer cells are denser, larger and more irregularly shaped than normal cells, they cause distinctive scattering in the light waves as they pass through,” said Louie. “We were able to invent a novel way to interpret these patterns instantaneously.”
Imaging devices to assist cancer detection are not new, but this optical probe can extract measurements without needing expensive lenses or cameras, and it can provide a more easily interpreted numerical result like those of a thermometer. Although the probe’s components cost only a few hundred dollars total, it is not envisioned to be a consumer product.
“A cancer screening tool should be administered by a trained health care professional who would know where the patient needs to go afterwards,” said Tim Lee, an associate professor of skin science and dermatology at UBC and a senior scientist at both BC Cancer and the Vancouver Coastal Health Research Institute, who supervised the work. He believes the device would be a good future addition to standard cancer screening methods, but not a replacement.
Noting that about 7,200 new cases of melanoma are reported every year in Canada, Lee believes the probe can promote early detection of this cancer.
“We have so few dermatologists relative to the growing number of skin cancers that are occurring,” said Lee. “If we can develop a device that can be integrated easily into other parts of the health care system, we can simplify the screening process and potentially save hundreds if not thousands of lives.”
The study, described in the Journal of Biomedical Optics, involved 69 lesions from 47 volunteer patients at the Vancouver General Hospital Skin Care Centre and is a joint project among UBC, BC Cancer and VCHRI. For their next steps, the researchers hope to eventually achieve Health Canada certification and approval before being able to offer this testing through health professionals. This will require further refinement of their technology and additional clinical testing in more patients.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Study shows risk of melanoma can be detected before appearance of moleson October 7, 2020 at 6:30 pm
The risk of developing melanoma, a deadly skin cancer, can be estimated long before detection of any suspicious moles, new research suggests.
- Iovance Stock Down on Delay in Filing for Melanoma Candidateon October 7, 2020 at 8:32 am
Shares of Iovance Biotherapeutics, Inc. IOVA fell about 12.4% after it announced that it will delay its biologics license application (BLA) submission to the FDA for its tumor-infiltrating lymphocyte ...
- Risk of melanoma may be gauged long before suspicious moles appear – studyon October 7, 2020 at 6:02 am
Research suggests genomic methods used to probe skin damage could be developed to estimate baseline risk of the skin cancer.
- Iovance stock drops nearly 10% following snag with FDA over experimental melanoma treatmenton October 6, 2020 at 11:22 am
Shares of Iovance Biotherapeutics, which is building a commercial manufacturing and office complex at the Philadelphia Navy Yard, were down 10% Tuesday on news about its experimental melanoma ...
- Iovance's stock tumbles over questions about regulatory submission for melanoma drugon October 6, 2020 at 5:08 am
Shares of Iovance Biotherapeutics Inc. were down 20.0% in premarket trading on Tuesday, the day after the biotechnology company said it plans to now submit an application to the Food and Drug ...
- Iovance Biotherapeutics Provides Update for Lifileucel in Metastatic Melanomaon October 5, 2020 at 1:01 pm
(GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today provided a regulatory update for its ...
- Bristol Myers Opdivo + Yervoy again shows underwhelming response in melanoma studyon October 5, 2020 at 4:50 am
Bristol (NYSE:BMY) announces results for the co-primary endpoint for CheckMate-915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for patients ...
- Ultimovacs Announces Positive Topline Results from Phase I Combination Trial Evaluating Universal Cancer Vaccine, UV1, in Malignant Melanoma Patientson September 30, 2020 at 8:27 am
Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced positive topline results from the first cohort of 20 patients in its ongoing US-based Phase I clinical trial evaluating the Company’s lead ...
- Melanoma Detection Market 2020 : Top Countries Data with Market Size, Share, Growth Analysis, Industry basis of Region to 2026on September 30, 2020 at 2:18 am
Melanoma Detection Market"Research Report 2020-2026 provides key analysis on the market status of the Melanoma ...
- Melanoma Drugs Market 2020 is Evolving Rapidly with Economic Growth, Demand Analysis, Geographical Segmentation and Forthcoming Opportunitieson September 28, 2020 at 8:46 pm
The Global Melanoma Drugs Market 2020 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2026 Analysis, Latest Innovations, Impacting Factors, ...
via Bing News